MicroRNA-214–5p involves in the protection effect of Dexmedetomidine against neurological injury in Alzheimer’s disease via targeting the suppressor of zest 12
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Brain Research Bulletin
- Vol. 178, 164-172
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (6 207625 3)
- Guangzhou Municipal Science and Technology Project (2 0190401038 9)
This publication has 28 references indexed in Scilit:
- SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinomaJournal of Cellular and Molecular Medicine, 2018
- Retracted: Effects of microRNA‐206 and its target gene IGF‐1 on sevoflurane‐induced activation of hippocampal astrocytes in aged rats through the PI3K/AKT/CREB signaling pathwayJournal of Cellular Physiology, 2017
- Biomarkers for Alzheimer's Disease DiagnosisCurrent Alzheimer Research, 2017
- MiR-214-3p attenuates cognition defects via the inhibition of autophagy in SAMP8 mouse model of sporadic Alzheimer's diseaseNeuroToxicology, 2016
- The EZH1–SUZ12 complex positively regulates the transcription of NF-κB target genes through interaction with UXTJournal of Cell Science, 2016
- Drug treatments in Alzheimer’s diseaseClinical Medicine, 2016
- Dexmedetomidine improves early postoperative cognitive dysfunction in aged miceEuropean Journal of Pharmacology, 2015
- Desflurane accelerates neuronal cytotoxicity of Aβ by downregulating miR-214Neuroscience Letters, 2013
- Isoflurane Increases Neuronal Cell Death Vulnerability by Downregulating miR-214PLOS ONE, 2013
- The histone H3K27 methylation mark regulates intestinal epithelial cell density‐dependent proliferation and the inflammatory responseJournal of Cellular Biochemistry, 2012